From Prototype to Profit: Commercialization Insights
4 months ago
Iridex Beats Profit Forecasts on Cost Cuts Amidst Revenue Dip
Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.
Read full article